The true cost of a 1 USD per test: to automate or not to automate the production

17 Jun, 2021
Now available on demand!

About the webinar

The life of a product comprises different stages from the original idea to its commercialization. A very important step for the overall success of the product, is the transition from the design to the manufacturing process.

The expected sales figures are not usually reached in real life. So, is it worth to invest in an automated manufacturing plant? Could it be better a lower risk option offered by a Contract Manufacturing Service?

If you have ever considered this, all the key points for a successful and cost-effective transfer process from small to high scale production will be shared based on our practical cases experience.

Meet the speakers

Stephanie Pigeot-Remy, Ph.D., Product Manager Life Sciences AHLSTROM-MUNKSJÖ

Stephanie Pigeot-Rémy holds a Ph.D. in Chemistry and Microbiology from Lyon 1 University. After a post-doctoral fellowship at the Collège de France, she joined Ahlstrom-Munksjö in 2014. She has over 15 years of experience in developing innovative products and new strategic businesses in Life Sciences and Diagnostics.

View full CV on LinkedIn

Virginia León Navas, PhD., LF Product Specialist - Sales & Marketing Department - OPERON S.A.

Virginia obtained a Science Bachelor’s degree in Biochemistry and a PhD in Science from Zaragoza University in Spain. Since 2015, she works as LF Product Specialist at the Sales & Marketing Department designing product specifications, providing technical support and managing contract manufacturing accounts.

View full CV on LinkedIn

The true cost of a 1 USD per test: to automate or not to automate the production - Watch on-demand

You can read Ahlstrom-Munksjö privacy statement at the following link.

Link to privacy policy.